Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
Malaysia may give foreign insurers more time to sell stakes

2018-06-29 thestar.com.my
Singapore’s Great Eastern Holdings Ltd and Japan’s Tokio Marine Holdings Inc were also among those weighing deals to cut local stakes, people familiar said last year.
ZURVY PUK.PRA PUK TKOMF PUK.PR GEHDF 8766 GEHDY TKOMY ZFSVF PUKPF

2
Bank Negara said to mull giving extensions for insurer stake sales

2018-06-28 theedgemarkets
(June 28): Malaysia’s central bank is considering granting extensions to some foreign insurers to give them more time to trim stakes in their local ventures, people with knowledge of the matter said.
ZURVY PUK.PRA PUK TKOMF PUK.PR GEHDF 8766 GEHDY TKOMY ZFSVF PUKPF

0
Prudential said to file for potential US$700 mil Malaysia IPO

2018-06-28 theedgemarkets
(June 28): Prudential Plc has filed for a potential listing of its Malaysian unit as the insurer explores options to reduce its stake in the business, people with knowledge of the matter said.
PUK.PRA PUK TKOMF PUK.PR 8766 GEHDF GEHDY TKOMY PUKPF

6
Canada's Sun Life sees Asia profit doubling, eyes bigger stake in China venture

2018-06-27 reuters
HONG KONG (Reuters) - Canada’s Sun Life Financial Inc expects to double its profit in Asia over the next five years on strong demand for insurance in key markets like China where it was keen to raise its ownership in a joint venture, its chief executive said.
SLF PUK.PRA SLF PUK PUK.PR SLF.PR.G SLFYF SLF.PR.B SLF.PR.E PUKPF SLF.PR.D SLF

6
Canada's Sun Life sees Asia profit doubling, eyes bigger stake in China venture

2018-06-27 theedgemarkets
HONG KONG (June 27): Canada's Sun Life Financial Inc expects to double its profit in Asia over the next five years on strong demand for insurance in key markets like China where it was keen to raise its ownership in a joint venture, its chief executive said.
SLF PUK.PRA SLF PUK PUK.PR SLF.PR.G SLFYF SLF.PR.B SLF.PR.E PUKPF SLF.PR.D SLF

1
AXA's Accelerated Transformation Carries Bigger Risks

2018-06-20 seekingalpha
AXA is in the middle of a wide-ranging transformation that will see it shift away from the U.S. (towards emerging markets) and away from life in favor of P&C.
PUK.PRA PUK PUK.PR EQH XL XLGLF PUKPF

0
Appointment of Director

2018-06-19 globenewswire
(Including Middlefield Canadian Income - GBP PC (the "Fund"), a cell of the Company Registered No: 93546)
PUK.PRA PUK PUK.PR PUKPF

3
News of TCS share buyback offer propels shares up 3%

2018-06-13 livemint
Mumbai: Shares of Tata Consultancy Services Ltd (TCS) gained 2.8% in morning trade on Wednesday after the company said its board of directors will meet on 15 June to consider share buyback.
WIT 532540 PUK.PRA PUK PUK.PR INFY TCS TTNQY PUKPF

5
TCS eyes $1.36 billion over 10 years from deal with Prudential arm

2018-06-12 livemint
Bengaluru: Tata Consultancy Services Ltd (TCS) expects to generate $1.36 billion in revenue over 10 years from its partnership with a unit of British insurer Prudential Plc.
INFY TCHQY TTNQY 532755 TECHM WIT 532540 PUK.PRA PUK PUK.PR TCS AGN PUKPF

0
Insurer Lincoln National could see upside -Barron's

2018-06-03 reuters
NEW YORK (Reuters) - U.S. insurer Lincoln National Corp could deliver shareholder returns of 20 percent or more in the coming year, as the market for the company’s main product, variable annuities, recovers, Barron’s reported.
LNC PUK.PRA PUK PUK.PR LNC.WS PUKPF

4
MetLife Moving Past Some Self-Inflicted Challenges And Toward Unlocking Value

2018-05-22 seekingalpha
MetLife has hurt its own cause with inconsistent results, while also seeing market pressures in several business and ROE drag from its run-off operations.
PUK.PRA PUK PUK.PR MET PRU PUKPF

19
AG / First Majestic Silver Corp. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-05-21 fintel.io
First Majestic Silver Corp. (NYSE:AG) has 151 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 69,255,077 shares. Largest shareholders include Wheaton Precious Metals Corp., Van Eck Associates Corp, Morgan Stanley, Vanguard Group Inc, Global X Management CO LLC, Credit Suisse Ag/, Prudential Plc, Connor, Clark & Lunn Investment Management Ltd.
WPM FR MS.PRE MS.PRF MS.PRG MS.PRA PUK.PRA MS.PRI PUK MS.PRK PUK.PR AG MS PUKPF

50
Why Barclays Mortgage Deal is Not a Sign to Enter Ireland

2018-05-21 zacks
Last week, Barclays (BCS - Free Report) acquired £4.3 billion ($5.8 billion) worth of Irish residential mortgage loans from Lloyds Banking Group (LYG - Free Report) . The portfolio comprises around 27,000 mortgages, originated between 2004 and 2010. Of the total loans acquired, nearly £300 million are impaired. Mortgage loan portfolio incurred a pre-tax loss of roughly £40 million in 2017. Notably, Lloyds is expected to record £110 million in pre-tax loss on the deal in second-quarter 2018.
WFCNP WFC.PRL WFC.PRJ PRU WFC.PRT WFC.PRR PUK.PRA WFC.PRQ WFC.PRP LLOBF WFC.PRO PUK WFC.PRN 8306 WFC.PRY WFC.PRX MBFJF WFC.PRW CSIQ WFC.PRV PUKPF WFC WFC.WS LLOY LYG LLPH LLPK LLPJ LLPE LLPD LLPG PUK.PR MUFG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 MTU LLD2

7
Noble Restructuring in Doubt as Founder Pushes for New Deal - Bloomberg

2018-04-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PUK.PRA NOBGF N21 PUK NOBGY PUK.PR PUKPF

12
Noble Group's week of woe gets worse as miner sues

2018-03-24 thestar.com.my
JAKARTA: Noble Group Ltd’s week of woe just got a lot worse as the trader, which has defaulted and seen founder Richard Elman quit the board, was sued by an Indonesian coal miner for more than US$250mil in a case that may jeopardise some of its remaining business.
DBSDY D05 PUK.PRA NOBGF N21 PUK DBSDF NOBGY PUK.PR PUKPF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 000709954